CD44 and cancer: Additionally, western blot and RT-qPCR analysis confirmed the positive regulation of CBX7 and IGF-1R on cancer stem cell markers CD133 and CD44, rescuing the negative influence of FOXC1 knockdown on these markers (Fig. 4G, H).